Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: BIOCRYST PHARMACEUTICALS INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2007-01-03 to 2014-04-30
Current total value of award: $204984698.95
Description: THE PURPOSE OF THIS MODIFICATION IS TO DEOBLIGATE EXCESS FUNDS AND CLOSE THIS CONTRACT.  IN ACCORDANCE WITH FAR 4.804-5.